We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Publishes Final Guidance on the Use of PROs in Device Clinical Trials
FDA Publishes Final Guidance on the Use of PROs in Device Clinical Trials
The FDA has kicked off the new year with attention to medical device trials, issuing final guidance with detailed recommendations for using patient reported outcomes (PROs).